| PSIJX | WCMLX | PSIJX / WCMLX | |
| Total Expense Ratio | 1.14 | 0.99 | 115% |
| Annual Report Gross Expense Ratio | 1.16 | 1.79 | 65% |
| Fund Existence | 25 years | 7 years | - |
| Gain YTD | 23.828 | 13.517 | 176% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 100000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.59B | 54.2M | 4,782% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | 16.45 | 22.61 | 73% |
| Returns for 3 years | 20.11 | 28.03 | 72% |
| Returns for 5 years | -20.79 | 3.79 | -549% |
| Returns for 10 years | 12.96 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| CRCD | 6.59 | 0.58 | +9.65% |
| T-REX 2X Inverse CRCL Daily Target ETF | |||
| OPER | 100.21 | 0.01 | +0.01% |
| ClearShares Ultra-Short Maturity ETF | |||
| SNPD | 29.96 | N/A | N/A |
| Xtrackers S&P Div Arstcrts Scrn ETF | |||
| BME | 42.95 | -0.06 | -0.14% |
| Blackrock Health Sciences Trust | |||
| DFAE | 38.14 | -1.27 | -3.22% |
| Dimensional Emerging Core Equity Mkt ETF | |||